U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07119190) titled 'A Perioperative Comprehensive Diagnosis and Treatment System for Lung Cancer in the Era of Neoadjuvant Immunotherapy' on July 15.
Brief Summary: The goal of this study is to develop and refine an integrated minimally invasive care pathway for resectable lung cancer in the immunotherapy era, establishing a novel precision perioperative immunotherapy paradigm encompassing original techniques and clinical applications.
Study Start Date: Aug. 06
Study Type: OBSERVATIONAL
Condition:
Non-Small Cell Lung Cancer
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Peking University People's Hospital
Information provided by (Responsible Pa...